T. Rowe Price Investment Management, Inc.

Position in ALKS — Alkermes plc.

CIK 1897612 BALTIMORE, MD

Back to ALKS Full portfolio

Position in ALKS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$31,621,599

+$31,562,869 QoQ

Shares Held

894,276

+42504.9% QoQ

Ownership

0.537%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

3 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

T. Rowe Price Investment Management, Inc. holds $877,868,421 across 3 Drug Manufacturers - Specialty & Generic names. ALKS ranks #2 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	34,635,086	$828,817,607
2	ALKS	Alkermes plc. This page	894,276	$31,621,599
3	PRGO	PERRIGO Co plc	1,622,832	$17,429,215

All Filings in ALKS

Export CSV

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$31,621,599	894,276	+42504.9%	Shares	Sole	2026-05-15
2025-12-31	$58,730	2,099	-100.0%	Shares	Sole	2026-02-19
2022-09-30	$101,887,502	4,562,808	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.